Pacific Biosciences of California Inc. (NASDAQ: PACB) is a biotechnology company that designs, develops, and commercializes a variety of tools for biological research.
Specifically, the company develops next generation DNA-sequencing systems to assist in resolving complex genetical problems.
PacBio’s DNA-sequence systems provide access to a wide range of applications that are designed to improve the accuracy and preciseness of the human, animal, and plant DNAs they test.
The company’s latest sequencing system, known as the “Sequel II,” was released in October 2020 and runs an application called “SMRT Link,” which can assemble genomes with 99.999% accuracy.
As you can tell from the chart above, PACB was trading for $10.50 at the beginning of October 2020.
Since then, it has rocketed 321% higher to $44.20 per share.
That could very well have something to do with the earnings Sequel II is bringing in…
PacBio went from losing $84.1 million in fiscal 2019 to profiting $29.4 million in 2020.
In fact, last year was the company’s first full year with a profit.
And with a full year of the Sequel II in 2021, investors can reasonably expect those profits to continue…
If profits increase, Cathie Wood will likely keep PACB as a core holding in ARKG for the foreseeable future.
Jeff Brown is arguably America’s #1 most accurate technology investor.
In 2015, he singled out Bitcoin before it shot up almost 100x…
He also recommended the #1 tech investments of 2016, 2018, 2019, and 2020!
Recently, Mr. Brown sat down with Chris Hurt to discuss the state of the stock market…
As you’ll see, it’s in an industry that billionaires like
Jeff Bezos and Warren Buffett are flocking to it…
(In fact, Buffett recently dumped $800 million of Apple stock to invest in this!)
It’s also set to grow an astonishing 5,900%.
If you have any interest in tech stocks, you can’t miss this special interview. And the new report Jeff Brown put together.
P.S. As you’ll see, there is some urgency with Mr. Brown’s #1 pick… His top company is set to release a revolutionary new product as early as March 1st, which could send the stock soaring.